Hitoshi Nakazato
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Nephrology top 2%
- Physiology
- Pathology and Forensic Medicine top 10%
- Co-authors
- Ryuji SuzukiYuji TsurutaHisashi OkuShoji YamaneTatsuya HorikawaKoichi NakanishiKazumoto IijimaMasataka Honda
- Topics
- Renal Diseases and Glomerulopathies (23 papers)Ion Transport and Channel Regulation (5 papers)Chronic Kidney Disease and Diabetes (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEAnnals of Neurology
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Hitoshi Nakazato
51 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 101
- Molecular Biology 651
- Pulmonary and Respiratory Medicine 349
- Nephrology 329
- Physiology 144
- Pathology and Forensic Medicine 120
Countries citing papers authored by Hitoshi Nakazato
This map shows the geographic impact of Hitoshi Nakazato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Nakazato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Nakazato more than expected).
Fields of papers citing papers by Hitoshi Nakazato
This network shows the impact of papers produced by Hitoshi Nakazato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Nakazato. The network helps show where Hitoshi Nakazato may publish in the future.
Co-authorship network of co-authors of Hitoshi Nakazato
This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Nakazato. A scholar is included among the top collaborators of Hitoshi Nakazato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Nakazato. Hitoshi Nakazato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 11 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 1 | |
| 9 | 36 | |
| 10 | 38 | |
| 11 | 26 | |
| 12 | 16 | |
| 13 | 37 | |
| 14 | 138 | |
| 15 | 152 | |
| 16 | 63 | |
| 17 | 19 | |
| 18 | 21 | |
| 19 | 5 | |
| 20 | [MLF syndrome (author's transl)]. | 0 |
About Hitoshi Nakazato
Hitoshi Nakazato is a scholar working on Nephrology, Hematology and Immunology and Allergy, having authored 56 papers that have together received 1.3k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (23 papers), Ion Transport and Channel Regulation (5 papers) and Chronic Kidney Disease and Diabetes (5 papers). The work is most often cited by research in Nephrology (329 citations), Pulmonary and Respiratory Medicine (349 citations) and Molecular Biology (651 citations). Hitoshi Nakazato has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Ryuji Suzuki, Yuji Tsuruta, Hisashi Oku, Shoji Yamane, Tatsuya Horikawa, Koichi Nakanishi, Kazumoto Iijima, Masataka Honda, Norishige Yoshikawa and Kenji Ishikura. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.